DUBLIN, March 5, 2021 /PRNewswire/ — The “Tissue Processing Systems Market Forecast to 2027 – COVID-19 Impact and Global Analysis By Product, Volume, and End User and Geography” report has been added to ResearchAndMarkets.com’s offering.
According to this report the global tissue processing systems market is expected to reach US$ 493.76 million by 2027 from US$ 335.78 million in 2019; it is estimated to grow at a CAGR of 5.1%from 2020 to 2027. The report highlights trends prevailing in the global tissue processing systems market, and the factors governing the market growth.
On the basis of end user, the tissue processing systems market is segmented into hospitals, pharmaceutical companies, research laboratories, and others. The hospitals segment held the largest share of the market in 2019. However, the pharmaceutical companies segment is estimated to register the highest CAGR in the market during the forecast period. Pharmaceutical companies are constant striving to identify new diagnostic and therapeutic methods for treating chronic diseases. Growing biopharmaceutical industry is also likely to favor the growth of the market for this segment. As per the Pharmaceutical Research and Manufacturers Association (PhRMA), US companies conduct more than half of the world’s R& D in pharmaceuticals (costing ~US$ 75 billion) and hold the intellectual property rights on most new medicines.
The global tissue processing systems market growth is mainly attributed to as the increasing…
